Across TCGA pan-cancer cohorts, QRSL1P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of QRSL1P2’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where QRSL1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types QRSL1P2 is over-expressed in tumor.
UCEC are the cancer types where QRSL1P2 tumor–normal differential expression is most reproducible.